Загрузка...
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women
CONTEXT: In the Women's Health Initiative estrogen plus progestin trial, after mean (SD) intervention of 5.6 (1.3) years (range 3.7 to 8.6 years) and mean follow-up of 7.9 (1.4) years, breast cancer incidence was increased by combined hormone therapy. However, breast cancer mortality results ha...
Сохранить в:
Опубликовано в: : | JAMA |
---|---|
Главные авторы: | , , , , , , , , , , , , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
2010
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5142300/ https://ncbi.nlm.nih.gov/pubmed/20959578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2010.1500 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|